David C. Ott, 10% Owner at Urovant Sciences Ltd. (UROV), bought 14,797 shares at $9995.00 ($99.9M) on 2019-05-21, disclosed to the SEC on 2019-05-23.
Scheduled purchase ($99.9M) by 10% Owner under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $9995.00 | 9,995 | $99.9M | 100.0% |
| 2 | $7.76 | 4,802 | $37K | 0.0% |
| Total | $6753.89 avg | 14,797 | $99.9M | 100% |
| Filing → |
| ROIV | SELL | 2023-06-26 | $257.4M | — | Filing → |
| FLAC | BUY | 2022-11-04 | $17.1M | — | Filing → |
| INBX | BUY | 2022-10-12 | $40.0M | — | Filing → |